Orogard SG Gel is a topical analgesic formulation containing Choline Salicylate 8.7% w/w and Lidocaine 2% w/w, designed for the symptomatic relief of pain and inflammation associated with oral mucosal conditions. Choline Salicylate, a non-steroidal anti-inflammatory agent, exerts its effect by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins involved in pain and inflammatory responses. Lidocaine, a local anesthetic, provides rapid onset of analgesia by blocking sodium channels in neuronal membranes, preventing nerve impulse conduction. The combination of these active ingredients ensures both immediate pain relief and sustained anti-inflammatory action, making Orogard SG Gel effective in managing discomfort from mouth ulcers, denture irritation, minor oral trauma, and other inflammatory oral lesions. The gel formulation facilitates easy application and adherence to the affected mucosal surfaces, enhancing local drug bioavailability while minimizing systemic absorption. Orogard SG Gel is intended for short-term use and should be applied as directed by a healthcare professional. Caution is advised in patients with known hypersensitivity to salicylates or local anesthetics. It is contraindicated in individuals with severe hepatic or renal impairment. Overall, Orogard SG Gel offers a targeted therapeutic approach for oral pain management with a favorable safety profile.